Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,763
Views
1
CrossRef citations to date
0
Altmetric
HPV – Research Paper

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial

Zhao-Jun Moa Expanded Program on Immunization Department, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information
,
Zhao-Feng Bib State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Wei Shengb State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Qi Chenb State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Teng Huanga Expanded Program on Immunization Department, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information
,
Ming-Qiang Lic Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, ChinaView further author information
,
Xue-Lian Cuic Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, ChinaView further author information
,
Ya-Hui Wangjiangb State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Bi-Zhen Lind Vaccine R&D Department, Xiamen Innovax Biotech Company, Xiamen, Fujian, ChinaView further author information
,
Feng-Zhu Zhengd Vaccine R&D Department, Xiamen Innovax Biotech Company, Xiamen, Fujian, ChinaView further author information
,
Guang Sund Vaccine R&D Department, Xiamen Innovax Biotech Company, Xiamen, Fujian, ChinaView further author information
,
Ya-Fei Lib State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Ya Zhengb State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Si-Jie Zhuangb State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Ying-Ying Sub State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaView further author information
,
Hui-Rong Pand Vaccine R&D Department, Xiamen Innovax Biotech Company, Xiamen, Fujian, ChinaCorrespondence[email protected]
View further author information
,
Shou-Jie Huangb State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaCorrespondence[email protected]
View further author information
,
Ting Wub State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1806-3056View further author information
ORCID Icon,
Jun Zhangb State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaORCID Iconhttps://orcid.org/0000-0002-6601-9180View further author information
ORCID Icon &
Ning-Shao Xiab State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, Xiamen University, Xiamen, Fujian, ChinaORCID Iconhttps://orcid.org/0000-0003-0179-5266View further author information
ORCID Icon show all
Article: 2092363 | Received 15 Apr 2022, Accepted 17 Jun 2022, Published online: 14 Jul 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.